Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
1601 Initial Results of Bladder Preserving Approach by Chemo-Radiotherapy in Patients with Muscle Invading Transitional Cell Carcinoma
 		Department of Radiotherapy and Nuclear medicine Prof. Mohammed Abdel-Hamid Ahmed Suleiman 2009
1602 Activation of nuclear factor kappa B and induction of migration inhibitory factor in tumors by surgical stress of laparotomy versus carbon dioxide pneumoperitoneum: an animal experiment Department of Surgical Oncology Dr. Anwar Tawfik Amin 2009
1603 Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial.
 		Department of Biostatistics and Cancer Epidemiology Nabiel Nazmi Hanna Mikhail 2009
1604 Initial Results of Bladder Preserving Approach by Chemo-Radiotherapy in Patients with Muscle Invading Transitional Cell Carcinoma
 		Department of Surgical Oncology Ahmed Mokhtar Abdel- Rahim Abdel-Moneem 2009
1605 The role of platelets CD40 ligand (CD154) in acute coronary syndromes Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2009
1606 Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma Department of Surgical Oncology Prof. Doaa Wadie Maximous Dawoud 2009
1607 A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Department of Biostatistics and Cancer Epidemiology Nabiel Nazmi Hanna Mikhail 2009
1608 Immunophenotyping and immunoglobulin heavy chain gene rearrangement analysis in cerebrospinal fluid of pediatric patients with acute lymphoblastic leukemia. Department of Clinical Pathology Prof. Mohamed Rafat / Mohammed Ibrahim Khalaf 2009
1609 A novel method for automated tumour delineation on PET/CT for radiotherapy treatment planning. Department of Radiotherapy and Nuclear medicine Dr. Moamen Mohamed Omran Moustafa Aly 2009
1610 Effect of Bevacizumab, a Humanized Monoclonal Antibody to Vascular
Endothelial Growth Factor, on Peritoneal Metastasis of MNK-45P
Human Gastric Cancer in Mice 		Department of Surgical Oncology Dr. Anwar Tawfik Amin 2009